nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Naloxone—CREB1—hematologic cancer	0.00563	0.383	CrCbGaD
Nalbuphine—Naltrexone—UGT1A1—hematologic cancer	0.00272	0.185	CrCbGaD
Nalbuphine—Morphine—UGT1A1—hematologic cancer	0.00168	0.114	CrCbGaD
Nalbuphine—Buprenorphine—ABCG2—hematologic cancer	0.00112	0.0765	CrCbGaD
Nalbuphine—Naloxone—ESR1—hematologic cancer	0.00109	0.0744	CrCbGaD
Nalbuphine—Naltrexone—ABCB1—hematologic cancer	0.000637	0.0434	CrCbGaD
Nalbuphine—Naloxone—ALB—hematologic cancer	0.000487	0.0331	CrCbGaD
Nalbuphine—Buprenorphine—ABCB1—hematologic cancer	0.000468	0.0319	CrCbGaD
Nalbuphine—Naloxone—ABCB1—hematologic cancer	0.000465	0.0316	CrCbGaD
Nalbuphine—Morphine—ABCB1—hematologic cancer	0.000392	0.0267	CrCbGaD
Nalbuphine—Dizziness—Vincristine—hematologic cancer	0.000249	0.000312	CcSEcCtD
Nalbuphine—Rash—Carmustine—hematologic cancer	0.000249	0.000312	CcSEcCtD
Nalbuphine—Dermatitis—Carmustine—hematologic cancer	0.000248	0.000311	CcSEcCtD
Nalbuphine—Vomiting—Alitretinoin—hematologic cancer	0.000248	0.000311	CcSEcCtD
Nalbuphine—Paraesthesia—Triamcinolone—hematologic cancer	0.000248	0.000311	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisolone—hematologic cancer	0.000248	0.000311	CcSEcCtD
Nalbuphine—Headache—Carmustine—hematologic cancer	0.000247	0.00031	CcSEcCtD
Nalbuphine—Shock—Dexamethasone—hematologic cancer	0.000247	0.000309	CcSEcCtD
Nalbuphine—Shock—Betamethasone—hematologic cancer	0.000247	0.000309	CcSEcCtD
Nalbuphine—Dyspnoea—Triamcinolone—hematologic cancer	0.000247	0.000309	CcSEcCtD
Nalbuphine—Rash—Alitretinoin—hematologic cancer	0.000246	0.000309	CcSEcCtD
Nalbuphine—Agitation—Prednisone—hematologic cancer	0.000246	0.000308	CcSEcCtD
Nalbuphine—Dermatitis—Alitretinoin—hematologic cancer	0.000246	0.000308	CcSEcCtD
Nalbuphine—Vomiting—Ifosfamide—hematologic cancer	0.000246	0.000308	CcSEcCtD
Nalbuphine—Hypersensitivity—Cisplatin—hematologic cancer	0.000245	0.000307	CcSEcCtD
Nalbuphine—Tachycardia—Dexamethasone—hematologic cancer	0.000245	0.000307	CcSEcCtD
Nalbuphine—Tachycardia—Betamethasone—hematologic cancer	0.000245	0.000307	CcSEcCtD
Nalbuphine—Bradycardia—Epirubicin—hematologic cancer	0.000245	0.000307	CcSEcCtD
Nalbuphine—Headache—Alitretinoin—hematologic cancer	0.000245	0.000307	CcSEcCtD
Nalbuphine—Nausea—Thalidomide—hematologic cancer	0.000244	0.000306	CcSEcCtD
Nalbuphine—Dyspepsia—Triamcinolone—hematologic cancer	0.000243	0.000305	CcSEcCtD
Nalbuphine—Rash—Ifosfamide—hematologic cancer	0.000243	0.000305	CcSEcCtD
Nalbuphine—Dermatitis—Ifosfamide—hematologic cancer	0.000243	0.000305	CcSEcCtD
Nalbuphine—Hyperhidrosis—Betamethasone—hematologic cancer	0.000243	0.000304	CcSEcCtD
Nalbuphine—Hyperhidrosis—Dexamethasone—hematologic cancer	0.000243	0.000304	CcSEcCtD
Nalbuphine—Dizziness—Irinotecan—hematologic cancer	0.000242	0.000304	CcSEcCtD
Nalbuphine—Urticaria—Etoposide—hematologic cancer	0.000242	0.000304	CcSEcCtD
Nalbuphine—Body temperature increased—Etoposide—hematologic cancer	0.000241	0.000302	CcSEcCtD
Nalbuphine—Abdominal pain—Etoposide—hematologic cancer	0.000241	0.000302	CcSEcCtD
Nalbuphine—Vertigo—Prednisone—hematologic cancer	0.000241	0.000302	CcSEcCtD
Nalbuphine—Syncope—Prednisone—hematologic cancer	0.00024	0.000301	CcSEcCtD
Nalbuphine—Hypoaesthesia—Epirubicin—hematologic cancer	0.000239	0.0003	CcSEcCtD
Nalbuphine—Vomiting—Vincristine—hematologic cancer	0.000239	0.0003	CcSEcCtD
Nalbuphine—Urticaria—Prednisolone—hematologic cancer	0.000239	0.000299	CcSEcCtD
Nalbuphine—Asthenia—Cisplatin—hematologic cancer	0.000239	0.000299	CcSEcCtD
Nalbuphine—Rash—Vincristine—hematologic cancer	0.000237	0.000297	CcSEcCtD
Nalbuphine—Dermatitis—Vincristine—hematologic cancer	0.000237	0.000297	CcSEcCtD
Nalbuphine—Headache—Vincristine—hematologic cancer	0.000236	0.000296	CcSEcCtD
Nalbuphine—Loss of consciousness—Prednisone—hematologic cancer	0.000235	0.000295	CcSEcCtD
Nalbuphine—Hypotension—Dexamethasone—hematologic cancer	0.000235	0.000294	CcSEcCtD
Nalbuphine—Hypotension—Betamethasone—hematologic cancer	0.000235	0.000294	CcSEcCtD
Nalbuphine—Nausea—Carmustine—hematologic cancer	0.000234	0.000294	CcSEcCtD
Nalbuphine—Vomiting—Mitoxantrone—hematologic cancer	0.000233	0.000292	CcSEcCtD
Nalbuphine—Vomiting—Irinotecan—hematologic cancer	0.000233	0.000292	CcSEcCtD
Nalbuphine—Nausea—Alitretinoin—hematologic cancer	0.000232	0.000291	CcSEcCtD
Nalbuphine—Convulsion—Prednisone—hematologic cancer	0.000232	0.000291	CcSEcCtD
Nalbuphine—Hypertension—Prednisone—hematologic cancer	0.000231	0.00029	CcSEcCtD
Nalbuphine—Rash—Mitoxantrone—hematologic cancer	0.000231	0.00029	CcSEcCtD
Nalbuphine—Rash—Irinotecan—hematologic cancer	0.000231	0.00029	CcSEcCtD
Nalbuphine—Dermatitis—Mitoxantrone—hematologic cancer	0.000231	0.000289	CcSEcCtD
Nalbuphine—Dermatitis—Irinotecan—hematologic cancer	0.000231	0.000289	CcSEcCtD
Nalbuphine—Headache—Mitoxantrone—hematologic cancer	0.00023	0.000288	CcSEcCtD
Nalbuphine—Headache—Irinotecan—hematologic cancer	0.00023	0.000288	CcSEcCtD
Nalbuphine—Nausea—Ifosfamide—hematologic cancer	0.000229	0.000287	CcSEcCtD
Nalbuphine—Feeling abnormal—Triamcinolone—hematologic cancer	0.000228	0.000286	CcSEcCtD
Nalbuphine—Anxiety—Prednisone—hematologic cancer	0.000227	0.000285	CcSEcCtD
Nalbuphine—Vomiting—Gemcitabine—hematologic cancer	0.000227	0.000285	CcSEcCtD
Nalbuphine—Bradycardia—Doxorubicin—hematologic cancer	0.000227	0.000284	CcSEcCtD
Nalbuphine—Paraesthesia—Dexamethasone—hematologic cancer	0.000225	0.000282	CcSEcCtD
Nalbuphine—Paraesthesia—Betamethasone—hematologic cancer	0.000225	0.000282	CcSEcCtD
Nalbuphine—Rash—Gemcitabine—hematologic cancer	0.000225	0.000282	CcSEcCtD
Nalbuphine—Dermatitis—Gemcitabine—hematologic cancer	0.000225	0.000282	CcSEcCtD
Nalbuphine—Hypersensitivity—Etoposide—hematologic cancer	0.000225	0.000282	CcSEcCtD
Nalbuphine—Erythema—Methotrexate—hematologic cancer	0.000224	0.00028	CcSEcCtD
Nalbuphine—Headache—Gemcitabine—hematologic cancer	0.000224	0.00028	CcSEcCtD
Nalbuphine—Nausea—Vincristine—hematologic cancer	0.000224	0.00028	CcSEcCtD
Nalbuphine—Flushing—Epirubicin—hematologic cancer	0.000223	0.00028	CcSEcCtD
Nalbuphine—Hypersensitivity—Prednisolone—hematologic cancer	0.000222	0.000278	CcSEcCtD
Nalbuphine—Hypoaesthesia—Doxorubicin—hematologic cancer	0.000222	0.000278	CcSEcCtD
Nalbuphine—Dyspepsia—Betamethasone—hematologic cancer	0.000221	0.000277	CcSEcCtD
Nalbuphine—Dyspepsia—Dexamethasone—hematologic cancer	0.000221	0.000277	CcSEcCtD
Nalbuphine—Urticaria—Triamcinolone—hematologic cancer	0.00022	0.000275	CcSEcCtD
Nalbuphine—Dysgeusia—Methotrexate—hematologic cancer	0.000219	0.000275	CcSEcCtD
Nalbuphine—Asthenia—Etoposide—hematologic cancer	0.000219	0.000274	CcSEcCtD
Nalbuphine—Body temperature increased—Triamcinolone—hematologic cancer	0.000219	0.000274	CcSEcCtD
Nalbuphine—Oedema—Prednisone—hematologic cancer	0.000219	0.000274	CcSEcCtD
Nalbuphine—Nausea—Mitoxantrone—hematologic cancer	0.000218	0.000273	CcSEcCtD
Nalbuphine—Nausea—Irinotecan—hematologic cancer	0.000218	0.000273	CcSEcCtD
Nalbuphine—Pruritus—Etoposide—hematologic cancer	0.000216	0.00027	CcSEcCtD
Nalbuphine—Shock—Prednisone—hematologic cancer	0.000215	0.000269	CcSEcCtD
Nalbuphine—Tachycardia—Prednisone—hematologic cancer	0.000213	0.000267	CcSEcCtD
Nalbuphine—Nausea—Gemcitabine—hematologic cancer	0.000212	0.000266	CcSEcCtD
Nalbuphine—Vomiting—Cisplatin—hematologic cancer	0.000212	0.000265	CcSEcCtD
Nalbuphine—Hyperhidrosis—Prednisone—hematologic cancer	0.000211	0.000265	CcSEcCtD
Nalbuphine—Vision blurred—Methotrexate—hematologic cancer	0.000211	0.000264	CcSEcCtD
Nalbuphine—Rash—Cisplatin—hematologic cancer	0.00021	0.000263	CcSEcCtD
Nalbuphine—Dermatitis—Cisplatin—hematologic cancer	0.00021	0.000263	CcSEcCtD
Nalbuphine—Erythema—Epirubicin—hematologic cancer	0.000209	0.000262	CcSEcCtD
Nalbuphine—Feeling abnormal—Betamethasone—hematologic cancer	0.000207	0.000259	CcSEcCtD
Nalbuphine—Feeling abnormal—Dexamethasone—hematologic cancer	0.000207	0.000259	CcSEcCtD
Nalbuphine—Flushing—Doxorubicin—hematologic cancer	0.000207	0.000259	CcSEcCtD
Nalbuphine—Tension—Epirubicin—hematologic cancer	0.000206	0.000258	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000205	0.000257	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000205	0.000257	CcSEcCtD
Nalbuphine—Dysgeusia—Epirubicin—hematologic cancer	0.000205	0.000257	CcSEcCtD
Nalbuphine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000204	0.000255	CcSEcCtD
Nalbuphine—Nervousness—Epirubicin—hematologic cancer	0.000203	0.000255	CcSEcCtD
Nalbuphine—Dizziness—Etoposide—hematologic cancer	0.000202	0.000253	CcSEcCtD
Nalbuphine—Muscle spasms—Epirubicin—hematologic cancer	0.000201	0.000252	CcSEcCtD
Nalbuphine—Vertigo—Methotrexate—hematologic cancer	0.000201	0.000252	CcSEcCtD
Nalbuphine—Urticaria—Betamethasone—hematologic cancer	0.000199	0.00025	CcSEcCtD
Nalbuphine—Urticaria—Dexamethasone—hematologic cancer	0.000199	0.00025	CcSEcCtD
Nalbuphine—Dizziness—Prednisolone—hematologic cancer	0.000199	0.000249	CcSEcCtD
Nalbuphine—Asthenia—Triamcinolone—hematologic cancer	0.000198	0.000249	CcSEcCtD
Nalbuphine—Abdominal pain—Dexamethasone—hematologic cancer	0.000198	0.000249	CcSEcCtD
Nalbuphine—Abdominal pain—Betamethasone—hematologic cancer	0.000198	0.000249	CcSEcCtD
Nalbuphine—Body temperature increased—Dexamethasone—hematologic cancer	0.000198	0.000249	CcSEcCtD
Nalbuphine—Body temperature increased—Betamethasone—hematologic cancer	0.000198	0.000249	CcSEcCtD
Nalbuphine—Nausea—Cisplatin—hematologic cancer	0.000198	0.000248	CcSEcCtD
Nalbuphine—Vision blurred—Epirubicin—hematologic cancer	0.000197	0.000247	CcSEcCtD
Nalbuphine—Paraesthesia—Prednisone—hematologic cancer	0.000196	0.000246	CcSEcCtD
Nalbuphine—Pruritus—Triamcinolone—hematologic cancer	0.000196	0.000245	CcSEcCtD
Nalbuphine—Convulsion—Methotrexate—hematologic cancer	0.000194	0.000243	CcSEcCtD
Nalbuphine—Vomiting—Etoposide—hematologic cancer	0.000194	0.000243	CcSEcCtD
Nalbuphine—Erythema—Doxorubicin—hematologic cancer	0.000194	0.000243	CcSEcCtD
Nalbuphine—Agitation—Epirubicin—hematologic cancer	0.000192	0.000241	CcSEcCtD
Nalbuphine—Dyspepsia—Prednisone—hematologic cancer	0.000192	0.000241	CcSEcCtD
Nalbuphine—Rash—Etoposide—hematologic cancer	0.000192	0.000241	CcSEcCtD
Nalbuphine—Dermatitis—Etoposide—hematologic cancer	0.000192	0.000241	CcSEcCtD
Nalbuphine—Headache—Etoposide—hematologic cancer	0.000191	0.000239	CcSEcCtD
Nalbuphine—Tension—Doxorubicin—hematologic cancer	0.00019	0.000238	CcSEcCtD
Nalbuphine—Dysgeusia—Doxorubicin—hematologic cancer	0.00019	0.000238	CcSEcCtD
Nalbuphine—Rash—Prednisolone—hematologic cancer	0.00019	0.000238	CcSEcCtD
Nalbuphine—Dermatitis—Prednisolone—hematologic cancer	0.000189	0.000237	CcSEcCtD
Nalbuphine—Headache—Prednisolone—hematologic cancer	0.000188	0.000236	CcSEcCtD
Nalbuphine—Nervousness—Doxorubicin—hematologic cancer	0.000188	0.000236	CcSEcCtD
Nalbuphine—Vertigo—Epirubicin—hematologic cancer	0.000188	0.000236	CcSEcCtD
Nalbuphine—Syncope—Epirubicin—hematologic cancer	0.000188	0.000235	CcSEcCtD
Nalbuphine—Muscle spasms—Doxorubicin—hematologic cancer	0.000186	0.000234	CcSEcCtD
Nalbuphine—Confusional state—Methotrexate—hematologic cancer	0.000184	0.000231	CcSEcCtD
Nalbuphine—Loss of consciousness—Epirubicin—hematologic cancer	0.000184	0.000231	CcSEcCtD
Nalbuphine—Dizziness—Triamcinolone—hematologic cancer	0.000183	0.000229	CcSEcCtD
Nalbuphine—Vision blurred—Doxorubicin—hematologic cancer	0.000183	0.000229	CcSEcCtD
Nalbuphine—Convulsion—Epirubicin—hematologic cancer	0.000181	0.000227	CcSEcCtD
Nalbuphine—Nausea—Etoposide—hematologic cancer	0.000181	0.000227	CcSEcCtD
Nalbuphine—Hypertension—Epirubicin—hematologic cancer	0.000181	0.000227	CcSEcCtD
Nalbuphine—Feeling abnormal—Prednisone—hematologic cancer	0.00018	0.000226	CcSEcCtD
Nalbuphine—Asthenia—Dexamethasone—hematologic cancer	0.00018	0.000226	CcSEcCtD
Nalbuphine—Asthenia—Betamethasone—hematologic cancer	0.00018	0.000226	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Prednisone—hematologic cancer	0.000179	0.000224	CcSEcCtD
Nalbuphine—Nausea—Prednisolone—hematologic cancer	0.000179	0.000224	CcSEcCtD
Nalbuphine—Agitation—Doxorubicin—hematologic cancer	0.000178	0.000223	CcSEcCtD
Nalbuphine—Anxiety—Epirubicin—hematologic cancer	0.000178	0.000223	CcSEcCtD
Nalbuphine—Pruritus—Betamethasone—hematologic cancer	0.000178	0.000223	CcSEcCtD
Nalbuphine—Pruritus—Dexamethasone—hematologic cancer	0.000178	0.000223	CcSEcCtD
Nalbuphine—Hyperhidrosis—Methotrexate—hematologic cancer	0.000177	0.000221	CcSEcCtD
Nalbuphine—Vomiting—Triamcinolone—hematologic cancer	0.000176	0.00022	CcSEcCtD
Nalbuphine—Rash—Triamcinolone—hematologic cancer	0.000174	0.000219	CcSEcCtD
Nalbuphine—Dry mouth—Epirubicin—hematologic cancer	0.000174	0.000219	CcSEcCtD
Nalbuphine—Dermatitis—Triamcinolone—hematologic cancer	0.000174	0.000218	CcSEcCtD
Nalbuphine—Vertigo—Doxorubicin—hematologic cancer	0.000174	0.000218	CcSEcCtD
Nalbuphine—Syncope—Doxorubicin—hematologic cancer	0.000174	0.000218	CcSEcCtD
Nalbuphine—Urticaria—Prednisone—hematologic cancer	0.000174	0.000218	CcSEcCtD
Nalbuphine—Headache—Triamcinolone—hematologic cancer	0.000173	0.000217	CcSEcCtD
Nalbuphine—Abdominal pain—Prednisone—hematologic cancer	0.000173	0.000217	CcSEcCtD
Nalbuphine—Body temperature increased—Prednisone—hematologic cancer	0.000173	0.000217	CcSEcCtD
Nalbuphine—Confusional state—Epirubicin—hematologic cancer	0.000172	0.000216	CcSEcCtD
Nalbuphine—Oedema—Epirubicin—hematologic cancer	0.000171	0.000214	CcSEcCtD
Nalbuphine—Hypotension—Methotrexate—hematologic cancer	0.000171	0.000214	CcSEcCtD
Nalbuphine—Loss of consciousness—Doxorubicin—hematologic cancer	0.00017	0.000213	CcSEcCtD
Nalbuphine—Shock—Epirubicin—hematologic cancer	0.000168	0.000211	CcSEcCtD
Nalbuphine—Convulsion—Doxorubicin—hematologic cancer	0.000168	0.00021	CcSEcCtD
Nalbuphine—Hypertension—Doxorubicin—hematologic cancer	0.000167	0.00021	CcSEcCtD
Nalbuphine—Tachycardia—Epirubicin—hematologic cancer	0.000167	0.000209	CcSEcCtD
Nalbuphine—Dizziness—Dexamethasone—hematologic cancer	0.000166	0.000208	CcSEcCtD
Nalbuphine—Dizziness—Betamethasone—hematologic cancer	0.000166	0.000208	CcSEcCtD
Nalbuphine—Hyperhidrosis—Epirubicin—hematologic cancer	0.000165	0.000207	CcSEcCtD
Nalbuphine—Anxiety—Doxorubicin—hematologic cancer	0.000164	0.000206	CcSEcCtD
Nalbuphine—Nausea—Triamcinolone—hematologic cancer	0.000164	0.000206	CcSEcCtD
Nalbuphine—Paraesthesia—Methotrexate—hematologic cancer	0.000164	0.000206	CcSEcCtD
Nalbuphine—Dyspnoea—Methotrexate—hematologic cancer	0.000163	0.000204	CcSEcCtD
Nalbuphine—Somnolence—Methotrexate—hematologic cancer	0.000162	0.000204	CcSEcCtD
Nalbuphine—Dry mouth—Doxorubicin—hematologic cancer	0.000161	0.000202	CcSEcCtD
Nalbuphine—Hypersensitivity—Prednisone—hematologic cancer	0.000161	0.000202	CcSEcCtD
Nalbuphine—Dyspepsia—Methotrexate—hematologic cancer	0.000161	0.000202	CcSEcCtD
Nalbuphine—Hypotension—Epirubicin—hematologic cancer	0.00016	0.0002	CcSEcCtD
Nalbuphine—Vomiting—Dexamethasone—hematologic cancer	0.00016	0.0002	CcSEcCtD
Nalbuphine—Vomiting—Betamethasone—hematologic cancer	0.00016	0.0002	CcSEcCtD
Nalbuphine—Confusional state—Doxorubicin—hematologic cancer	0.000159	0.0002	CcSEcCtD
Nalbuphine—Rash—Betamethasone—hematologic cancer	0.000158	0.000198	CcSEcCtD
Nalbuphine—Rash—Dexamethasone—hematologic cancer	0.000158	0.000198	CcSEcCtD
Nalbuphine—Oedema—Doxorubicin—hematologic cancer	0.000158	0.000198	CcSEcCtD
Nalbuphine—Dermatitis—Dexamethasone—hematologic cancer	0.000158	0.000198	CcSEcCtD
Nalbuphine—Dermatitis—Betamethasone—hematologic cancer	0.000158	0.000198	CcSEcCtD
Nalbuphine—Headache—Dexamethasone—hematologic cancer	0.000157	0.000197	CcSEcCtD
Nalbuphine—Headache—Betamethasone—hematologic cancer	0.000157	0.000197	CcSEcCtD
Nalbuphine—Asthenia—Prednisone—hematologic cancer	0.000157	0.000197	CcSEcCtD
Nalbuphine—Shock—Doxorubicin—hematologic cancer	0.000156	0.000195	CcSEcCtD
Nalbuphine—Pruritus—Prednisone—hematologic cancer	0.000155	0.000194	CcSEcCtD
Nalbuphine—Tachycardia—Doxorubicin—hematologic cancer	0.000154	0.000193	CcSEcCtD
Nalbuphine—Paraesthesia—Epirubicin—hematologic cancer	0.000154	0.000192	CcSEcCtD
Nalbuphine—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000153	0.000192	CcSEcCtD
Nalbuphine—Dyspnoea—Epirubicin—hematologic cancer	0.000152	0.000191	CcSEcCtD
Nalbuphine—Somnolence—Epirubicin—hematologic cancer	0.000152	0.00019	CcSEcCtD
Nalbuphine—Feeling abnormal—Methotrexate—hematologic cancer	0.000151	0.000189	CcSEcCtD
Nalbuphine—Dyspepsia—Epirubicin—hematologic cancer	0.00015	0.000189	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000149	0.000187	CcSEcCtD
Nalbuphine—Nausea—Betamethasone—hematologic cancer	0.000149	0.000187	CcSEcCtD
Nalbuphine—Nausea—Dexamethasone—hematologic cancer	0.000149	0.000187	CcSEcCtD
Nalbuphine—Hypotension—Doxorubicin—hematologic cancer	0.000148	0.000185	CcSEcCtD
Nalbuphine—Urticaria—Methotrexate—hematologic cancer	0.000145	0.000182	CcSEcCtD
Nalbuphine—Dizziness—Prednisone—hematologic cancer	0.000145	0.000181	CcSEcCtD
Nalbuphine—Abdominal pain—Methotrexate—hematologic cancer	0.000144	0.000181	CcSEcCtD
Nalbuphine—Body temperature increased—Methotrexate—hematologic cancer	0.000144	0.000181	CcSEcCtD
Nalbuphine—Paraesthesia—Doxorubicin—hematologic cancer	0.000142	0.000178	CcSEcCtD
Nalbuphine—Dyspnoea—Doxorubicin—hematologic cancer	0.000141	0.000177	CcSEcCtD
Nalbuphine—Feeling abnormal—Epirubicin—hematologic cancer	0.000141	0.000177	CcSEcCtD
Nalbuphine—Somnolence—Doxorubicin—hematologic cancer	0.000141	0.000176	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Epirubicin—hematologic cancer	0.00014	0.000175	CcSEcCtD
Nalbuphine—Dyspepsia—Doxorubicin—hematologic cancer	0.000139	0.000174	CcSEcCtD
Nalbuphine—Vomiting—Prednisone—hematologic cancer	0.000139	0.000174	CcSEcCtD
Nalbuphine—Rash—Prednisone—hematologic cancer	0.000138	0.000173	CcSEcCtD
Nalbuphine—Dermatitis—Prednisone—hematologic cancer	0.000138	0.000173	CcSEcCtD
Nalbuphine—Headache—Prednisone—hematologic cancer	0.000137	0.000172	CcSEcCtD
Nalbuphine—Urticaria—Epirubicin—hematologic cancer	0.000136	0.00017	CcSEcCtD
Nalbuphine—Abdominal pain—Epirubicin—hematologic cancer	0.000135	0.000169	CcSEcCtD
Nalbuphine—Body temperature increased—Epirubicin—hematologic cancer	0.000135	0.000169	CcSEcCtD
Nalbuphine—Hypersensitivity—Methotrexate—hematologic cancer	0.000135	0.000169	CcSEcCtD
Nalbuphine—Asthenia—Methotrexate—hematologic cancer	0.000131	0.000164	CcSEcCtD
Nalbuphine—Feeling abnormal—Doxorubicin—hematologic cancer	0.00013	0.000163	CcSEcCtD
Nalbuphine—Nausea—Prednisone—hematologic cancer	0.00013	0.000163	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Doxorubicin—hematologic cancer	0.000129	0.000162	CcSEcCtD
Nalbuphine—Pruritus—Methotrexate—hematologic cancer	0.000129	0.000162	CcSEcCtD
Nalbuphine—Hypersensitivity—Epirubicin—hematologic cancer	0.000126	0.000158	CcSEcCtD
Nalbuphine—Urticaria—Doxorubicin—hematologic cancer	0.000126	0.000157	CcSEcCtD
Nalbuphine—Abdominal pain—Doxorubicin—hematologic cancer	0.000125	0.000157	CcSEcCtD
Nalbuphine—Body temperature increased—Doxorubicin—hematologic cancer	0.000125	0.000157	CcSEcCtD
Nalbuphine—Asthenia—Epirubicin—hematologic cancer	0.000123	0.000154	CcSEcCtD
Nalbuphine—Pruritus—Epirubicin—hematologic cancer	0.000121	0.000152	CcSEcCtD
Nalbuphine—Dizziness—Methotrexate—hematologic cancer	0.000121	0.000151	CcSEcCtD
Nalbuphine—Hypersensitivity—Doxorubicin—hematologic cancer	0.000117	0.000146	CcSEcCtD
Nalbuphine—Vomiting—Methotrexate—hematologic cancer	0.000116	0.000146	CcSEcCtD
Nalbuphine—Rash—Methotrexate—hematologic cancer	0.000115	0.000144	CcSEcCtD
Nalbuphine—Dermatitis—Methotrexate—hematologic cancer	0.000115	0.000144	CcSEcCtD
Nalbuphine—Headache—Methotrexate—hematologic cancer	0.000114	0.000143	CcSEcCtD
Nalbuphine—Asthenia—Doxorubicin—hematologic cancer	0.000113	0.000142	CcSEcCtD
Nalbuphine—Dizziness—Epirubicin—hematologic cancer	0.000113	0.000142	CcSEcCtD
Nalbuphine—Pruritus—Doxorubicin—hematologic cancer	0.000112	0.00014	CcSEcCtD
Nalbuphine—Vomiting—Epirubicin—hematologic cancer	0.000109	0.000136	CcSEcCtD
Nalbuphine—Nausea—Methotrexate—hematologic cancer	0.000109	0.000136	CcSEcCtD
Nalbuphine—Rash—Epirubicin—hematologic cancer	0.000108	0.000135	CcSEcCtD
Nalbuphine—Dermatitis—Epirubicin—hematologic cancer	0.000108	0.000135	CcSEcCtD
Nalbuphine—Headache—Epirubicin—hematologic cancer	0.000107	0.000134	CcSEcCtD
Nalbuphine—Dizziness—Doxorubicin—hematologic cancer	0.000105	0.000131	CcSEcCtD
Nalbuphine—Nausea—Epirubicin—hematologic cancer	0.000102	0.000127	CcSEcCtD
Nalbuphine—Vomiting—Doxorubicin—hematologic cancer	0.000101	0.000126	CcSEcCtD
Nalbuphine—Rash—Doxorubicin—hematologic cancer	9.97e-05	0.000125	CcSEcCtD
Nalbuphine—Dermatitis—Doxorubicin—hematologic cancer	9.96e-05	0.000125	CcSEcCtD
Nalbuphine—Headache—Doxorubicin—hematologic cancer	9.91e-05	0.000124	CcSEcCtD
Nalbuphine—Nausea—Doxorubicin—hematologic cancer	9.4e-05	0.000118	CcSEcCtD
Nalbuphine—OPRD1—Signaling Pathways—FGF1—hematologic cancer	5.45e-05	0.000291	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—JAK2—hematologic cancer	5.4e-05	0.000288	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCR4—hematologic cancer	5.39e-05	0.000288	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HDAC2—hematologic cancer	5.39e-05	0.000288	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MAP2K1—hematologic cancer	5.38e-05	0.000287	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FOXO1—hematologic cancer	5.37e-05	0.000287	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—IL2—hematologic cancer	5.37e-05	0.000287	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PDGFRB—hematologic cancer	5.36e-05	0.000286	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GRB2—hematologic cancer	5.35e-05	0.000285	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CD—hematologic cancer	5.34e-05	0.000285	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PDGFA—hematologic cancer	5.33e-05	0.000285	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CB—hematologic cancer	5.31e-05	0.000283	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PDGFRA—hematologic cancer	5.28e-05	0.000282	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—JAK1—hematologic cancer	5.26e-05	0.000281	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PRKCG—hematologic cancer	5.26e-05	0.000281	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KITLG—hematologic cancer	5.26e-05	0.000281	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CBL—hematologic cancer	5.25e-05	0.00028	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL3—hematologic cancer	5.2e-05	0.000277	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT5A—hematologic cancer	5.14e-05	0.000274	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CG—hematologic cancer	5.13e-05	0.000274	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CB—hematologic cancer	5.13e-05	0.000274	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTPN1—hematologic cancer	5.11e-05	0.000273	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN2B—hematologic cancer	5.09e-05	0.000272	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PTPN11—hematologic cancer	5.04e-05	0.000269	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3R1—hematologic cancer	5.04e-05	0.000269	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—RASGRP1—hematologic cancer	5.03e-05	0.000268	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SYK—hematologic cancer	5.01e-05	0.000267	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HSP90AA1—hematologic cancer	5.01e-05	0.000267	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CD—hematologic cancer	4.97e-05	0.000265	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CD86—hematologic cancer	4.93e-05	0.000263	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL2RA—hematologic cancer	4.91e-05	0.000262	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—JAK2—hematologic cancer	4.9e-05	0.000262	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CREB1—hematologic cancer	4.89e-05	0.000261	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL2—hematologic cancer	4.87e-05	0.00026	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HES1—hematologic cancer	4.86e-05	0.000259	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TERT—hematologic cancer	4.86e-05	0.000259	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NCOR1—hematologic cancer	4.83e-05	0.000258	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT1—hematologic cancer	4.83e-05	0.000258	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CCL2—hematologic cancer	4.78e-05	0.000255	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CSF2—hematologic cancer	4.78e-05	0.000255	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGF1—hematologic cancer	4.78e-05	0.000255	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6R—hematologic cancer	4.77e-05	0.000254	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PDGFB—hematologic cancer	4.74e-05	0.000253	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FOXO1—hematologic cancer	4.71e-05	0.000251	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—IL2—hematologic cancer	4.71e-05	0.000251	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PDGFRB—hematologic cancer	4.7e-05	0.000251	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3R1—hematologic cancer	4.69e-05	0.000251	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CB—hematologic cancer	4.65e-05	0.000248	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TSC2—hematologic cancer	4.63e-05	0.000247	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PDGFRA—hematologic cancer	4.63e-05	0.000247	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PRKCG—hematologic cancer	4.61e-05	0.000246	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—JAK1—hematologic cancer	4.61e-05	0.000246	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—JAK2—hematologic cancer	4.56e-05	0.000243	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MAP2K1—hematologic cancer	4.54e-05	0.000243	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GRB2—hematologic cancer	4.52e-05	0.000241	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CD—hematologic cancer	4.51e-05	0.000241	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PDGFA—hematologic cancer	4.51e-05	0.000241	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGFR3—hematologic cancer	4.46e-05	0.000238	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KITLG—hematologic cancer	4.44e-05	0.000237	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK14—hematologic cancer	4.41e-05	0.000236	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT5A—hematologic cancer	4.34e-05	0.000232	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CB—hematologic cancer	4.33e-05	0.000231	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—ESR1—hematologic cancer	4.33e-05	0.000231	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL2RA—hematologic cancer	4.31e-05	0.00023	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN2B—hematologic cancer	4.31e-05	0.00023	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FN1—hematologic cancer	4.28e-05	0.000228	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL2—hematologic cancer	4.27e-05	0.000228	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3R1—hematologic cancer	4.26e-05	0.000228	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TERT—hematologic cancer	4.26e-05	0.000227	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—BAD—hematologic cancer	4.23e-05	0.000226	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NFKBIA—hematologic cancer	4.23e-05	0.000226	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOTCH1—hematologic cancer	4.18e-05	0.000223	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CD86—hematologic cancer	4.16e-05	0.000222	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PDGFB—hematologic cancer	4.16e-05	0.000222	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—JAK2—hematologic cancer	4.14e-05	0.000221	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HES1—hematologic cancer	4.11e-05	0.000219	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CD80—hematologic cancer	4.1e-05	0.000219	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CG—hematologic cancer	4.09e-05	0.000218	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KIT—hematologic cancer	4.09e-05	0.000218	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—NRAS—hematologic cancer	4.09e-05	0.000218	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NCOR1—hematologic cancer	4.08e-05	0.000218	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TSC2—hematologic cancer	4.06e-05	0.000217	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CSF2—hematologic cancer	4.04e-05	0.000216	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGF1—hematologic cancer	4.04e-05	0.000216	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTPN11—hematologic cancer	4.02e-05	0.000215	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FOXO1—hematologic cancer	3.98e-05	0.000212	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—IL2—hematologic cancer	3.98e-05	0.000212	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PDGFRB—hematologic cancer	3.97e-05	0.000212	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CB—hematologic cancer	3.93e-05	0.00021	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—MAPK3—hematologic cancer	3.92e-05	0.000209	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PDGFRA—hematologic cancer	3.91e-05	0.000209	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGFR3—hematologic cancer	3.91e-05	0.000209	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—JAK1—hematologic cancer	3.9e-05	0.000208	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PRKCG—hematologic cancer	3.9e-05	0.000208	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CREB1—hematologic cancer	3.9e-05	0.000208	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK14—hematologic cancer	3.87e-05	0.000207	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—BRAF—hematologic cancer	3.85e-05	0.000205	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCL2—hematologic cancer	3.81e-05	0.000203	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6R—hematologic cancer	3.8e-05	0.000203	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—ESR1—hematologic cancer	3.8e-05	0.000203	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CREBBP—hematologic cancer	3.79e-05	0.000203	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FN1—hematologic cancer	3.75e-05	0.0002	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NFKBIA—hematologic cancer	3.71e-05	0.000198	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—BAD—hematologic cancer	3.71e-05	0.000198	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOTCH1—hematologic cancer	3.67e-05	0.000196	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL2RA—hematologic cancer	3.64e-05	0.000194	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAP2K1—hematologic cancer	3.62e-05	0.000193	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL2—hematologic cancer	3.61e-05	0.000193	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TERT—hematologic cancer	3.6e-05	0.000192	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CD—hematologic cancer	3.6e-05	0.000192	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CD80—hematologic cancer	3.59e-05	0.000192	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KIT—hematologic cancer	3.59e-05	0.000192	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CG—hematologic cancer	3.59e-05	0.000192	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—NRAS—hematologic cancer	3.59e-05	0.000192	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.56e-05	0.00019	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTPN11—hematologic cancer	3.53e-05	0.000188	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—KRAS—hematologic cancer	3.52e-05	0.000188	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	3.51e-05	0.000188	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—FGF2—hematologic cancer	3.44e-05	0.000184	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—MAPK3—hematologic cancer	3.44e-05	0.000183	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TSC2—hematologic cancer	3.43e-05	0.000183	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CREB1—hematologic cancer	3.42e-05	0.000182	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3R1—hematologic cancer	3.4e-05	0.000181	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—BRAF—hematologic cancer	3.37e-05	0.00018	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCL2—hematologic cancer	3.34e-05	0.000178	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6R—hematologic cancer	3.33e-05	0.000178	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CREBBP—hematologic cancer	3.33e-05	0.000178	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	3.3e-05	0.000176	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—JAK2—hematologic cancer	3.3e-05	0.000176	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	3.27e-05	0.000175	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CA—hematologic cancer	3.24e-05	0.000173	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MDM2—hematologic cancer	3.22e-05	0.000172	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—ESR1—hematologic cancer	3.21e-05	0.000171	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAP2K1—hematologic cancer	3.18e-05	0.00017	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FN1—hematologic cancer	3.17e-05	0.000169	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CD—hematologic cancer	3.15e-05	0.000168	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CB—hematologic cancer	3.14e-05	0.000167	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MTOR—hematologic cancer	3.14e-05	0.000167	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—BAD—hematologic cancer	3.13e-05	0.000167	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	3.13e-05	0.000167	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.12e-05	0.000167	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	3.1e-05	0.000166	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	3.09e-05	0.000165	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CD80—hematologic cancer	3.04e-05	0.000162	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	3.03e-05	0.000162	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KIT—hematologic cancer	3.03e-05	0.000162	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	3.03e-05	0.000162	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—FGF2—hematologic cancer	3.02e-05	0.000161	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—HRAS—hematologic cancer	2.99e-05	0.00016	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	2.98e-05	0.000159	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	2.98e-05	0.000159	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CDKN1B—hematologic cancer	2.94e-05	0.000157	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AKT1—hematologic cancer	2.91e-05	0.000155	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	2.9e-05	0.000155	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—JAK2—hematologic cancer	2.9e-05	0.000155	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CREB1—hematologic cancer	2.89e-05	0.000154	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CASP3—hematologic cancer	2.88e-05	0.000154	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL2—hematologic cancer	2.88e-05	0.000154	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—IL6—hematologic cancer	2.87e-05	0.000153	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—BRAF—hematologic cancer	2.85e-05	0.000152	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	2.84e-05	0.000151	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MDM2—hematologic cancer	2.83e-05	0.000151	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCL2—hematologic cancer	2.82e-05	0.000151	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6R—hematologic cancer	2.82e-05	0.00015	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	2.81e-05	0.00015	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCND1—hematologic cancer	2.81e-05	0.00015	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—JUN—hematologic cancer	2.8e-05	0.00015	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	2.75e-05	0.000147	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MTOR—hematologic cancer	2.75e-05	0.000147	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CDKN1A—hematologic cancer	2.72e-05	0.000145	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTEN—hematologic cancer	2.71e-05	0.000145	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	2.68e-05	0.000143	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	2.67e-05	0.000142	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK8—hematologic cancer	2.65e-05	0.000142	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AKT1—hematologic cancer	2.64e-05	0.000141	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	2.64e-05	0.000141	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	2.63e-05	0.00014	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	2.61e-05	0.000139	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EP300—hematologic cancer	2.58e-05	0.000138	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	2.58e-05	0.000138	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—FGF2—hematologic cancer	2.55e-05	0.000136	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	2.55e-05	0.000136	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CASP3—hematologic cancer	2.53e-05	0.000135	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL2—hematologic cancer	2.53e-05	0.000135	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	2.52e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SRC—hematologic cancer	2.51e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—IL6—hematologic cancer	2.51e-05	0.000134	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCND1—hematologic cancer	2.46e-05	0.000131	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—JUN—hematologic cancer	2.46e-05	0.000131	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—VEGFA—hematologic cancer	2.45e-05	0.000131	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—JAK2—hematologic cancer	2.45e-05	0.000131	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STAT3—hematologic cancer	2.42e-05	0.000129	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NRAS—hematologic cancer	2.42e-05	0.000129	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	2.4e-05	0.000128	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MDM2—hematologic cancer	2.39e-05	0.000128	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	2.38e-05	0.000127	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTEN—hematologic cancer	2.38e-05	0.000127	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	2.32e-05	0.000124	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MTOR—hematologic cancer	2.32e-05	0.000124	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	2.32e-05	0.000124	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	2.32e-05	0.000124	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MAPK3—hematologic cancer	2.32e-05	0.000124	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EP300—hematologic cancer	2.27e-05	0.000121	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MYC—hematologic cancer	2.25e-05	0.00012	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TGFB1—hematologic cancer	2.25e-05	0.00012	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	2.22e-05	0.000118	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SRC—hematologic cancer	2.2e-05	0.000118	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	2.18e-05	0.000116	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	2.16e-05	0.000115	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	2.15e-05	0.000115	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CASP3—hematologic cancer	2.14e-05	0.000114	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL2—hematologic cancer	2.13e-05	0.000114	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT3—hematologic cancer	2.12e-05	0.000113	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IL6—hematologic cancer	2.12e-05	0.000113	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NRAS—hematologic cancer	2.12e-05	0.000113	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KRAS—hematologic cancer	2.08e-05	0.000111	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCND1—hematologic cancer	2.08e-05	0.000111	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—JUN—hematologic cancer	2.08e-05	0.000111	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	2.03e-05	0.000108	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	2.01e-05	0.000107	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTEN—hematologic cancer	2.01e-05	0.000107	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MYC—hematologic cancer	1.97e-05	0.000105	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	1.97e-05	0.000105	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	1.96e-05	0.000105	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	1.96e-05	0.000105	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EP300—hematologic cancer	1.91e-05	0.000102	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CA—hematologic cancer	1.91e-05	0.000102	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SRC—hematologic cancer	1.86e-05	9.94e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TP53—hematologic cancer	1.85e-05	9.87e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KRAS—hematologic cancer	1.82e-05	9.74e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	1.81e-05	9.68e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT3—hematologic cancer	1.8e-05	9.59e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NRAS—hematologic cancer	1.79e-05	9.56e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HRAS—hematologic cancer	1.77e-05	9.44e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	1.72e-05	9.16e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IL6—hematologic cancer	1.69e-05	9.04e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	1.68e-05	8.95e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MYC—hematologic cancer	1.67e-05	8.91e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	1.66e-05	8.89e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TP53—hematologic cancer	1.62e-05	8.66e-05	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT1—hematologic cancer	1.56e-05	8.34e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HRAS—hematologic cancer	1.55e-05	8.28e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KRAS—hematologic cancer	1.54e-05	8.23e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IL6—hematologic cancer	1.48e-05	7.92e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.42e-05	7.56e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TP53—hematologic cancer	1.37e-05	7.32e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT1—hematologic cancer	1.37e-05	7.31e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HRAS—hematologic cancer	1.31e-05	7e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IL6—hematologic cancer	1.25e-05	6.7e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT1—hematologic cancer	1.16e-05	6.18e-05	CbGpPWpGaD
